Kentucky 2022 Regular Session

Kentucky Senate Bill SB210

Introduced
2/23/22  
Refer
2/23/22  

Caption

AN ACT relating to consumer protections.

Impact

Under SB210, kratom processors and retailers will be prohibited from selling kratom products to individuals under the age of twenty-one. It also ensures that kratom products are free from dangerous non-kratom adulterants, including certain synthetic alkaloids. By enforcing these regulations, the bill seeks to safeguard consumers from potentially hazardous substances and misleading labeling, thereby influencing public health standards and consumer safety expectations within the marketplace. Violations of these provisions can lead to administrative fines imposed on offenders.

Summary

Senate Bill 210 (SB210) is a legislative act aimed at enhancing consumer protections regarding kratom products in the Commonwealth of Kentucky. The bill introduces several regulatory measures for kratom processors and retailers, establishing strict guidelines under which they can operate, particularly concerning the sale of kratom products to minors and the assurance of product safety and quality. It defines key terms related to kratom and delineates the responsibilities of those involved in the processing and selling of kratom extracts and products.

Sentiment

The sentiment surrounding SB210 appears to be supportive among those who prioritize consumer safety and public health, as it addresses the need for more stringent oversight of kratom products, which have garnered controversy due to their potential health risks. However, there may be contention within the kratom community regarding the implications of these regulations on their availability and accessibility, as some may argue that stringent restrictions could unduly limit consumer choices and infringe on personal freedoms.

Contention

Notable points of contention in the discussions around SB210 include the balance between ensuring consumer safety and the potential over-regulation of kratom products, which could lead to issues related to personal liberties and market access. Furthermore, concerns are raised about the implications of enforcing new labeling requirements on small businesses within the kratom industry, who may struggle to comply with the stringent standards while maintaining their operations. The overall discourse reflects a tension between safeguarding public health and preserving self-regulation within the marketplace.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.